ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Vitamin D supplementation extends life in mouse model of Huntington's disease

Omega-3 fatty acid stops known trigger of lupus

Conquer Your Email Inbox, Increase Productivity and Reduce Stress

Print Page
Email Article

Tips from the Journals of the American Society for Microbiology

  [ 46 votes ]   [ Discuss This Article ] • January 14, 2003

Strategy for Ulcer Vaccine Shows Promise

Researchers from Auburn University have developed a strategy that may lead to an effective vaccine against a common cause of ulcers. They report their findings in the January 2003 issue of the journal Infection and Immunity.

Helicobacter pylori bacteria were first isolated in the early 1980s and have since been shown to be a common cause of peptic ulcers and are also associated with some types of stomach cancer. Once identified, infections can be treated with antibiotics. There is currently no vaccine.

In the study the researchers developed a nasal vaccine that completely protected mice from infection with Helicobacter felis, a relative of H. pylori. H. felis infection in mice is currently accepted by researchers as a standard model for H. pylori vaccine development.

While the results are promising, more studies still need to be done, say the researchers.

(W. Jiang, H.J. Baker and B.F. Smith. 2003. Mucosal immunization with Helicobacter, CpG DNA, and cholera toxin is protective. Infection and Immunity, 71: 40-46.)

Sourdough compound delays mold growth

Bacteria isolated from sourdough bread produce a compound that inhibits the growth of molds. Researchers from the Institute of Sciences of Food Production in Bari, Italy, report their findings in the January 2003 issue of the journal Applied and Environmental Microbiology.

Sourdough bakery products have long been known to have longer shelf lives. In the study, the researchers identified an antifungal compound, known as phenyllactic acid (PLA), that is produced by a strain of the sourdough lactic acid bacterium Lactobacillus plantarum. When tested against a variety of fungi found in baked goods, the compound was able to delay growth by more than 2 days in some cases.

"The ability of PLA to act as a fungicide and delay growth a of a variety of fungal contaminants provides new perspectives for possibly using this natural antimicrobial compound to control fungal contaminants and extend the shelf lives of foods," say the researchers.

(P. Lavermicocca, F. Valerio and A. Visconti. 2003. Antifungal activity of phenyllactic acid against molds isolated from bakery products. Applied and Environmental Microbiology, 69: 634-640.)

Microbes harmful to inner ear potentially normal in outer ear canal
Organisms commonly associated with middle ear infections may exist as normal microbes in a healthy outer ear canal say researchers at the University of Colorado, University of British Columbia and the Molecular Sciences Institute. Their findings appear in the January 2003 issue of the Journal of Clinical Microbiology.

In the study, swab samples were taken from the outer ear of twenty-four individuals. The results showed the presence of Alloiococcus otitis and Corynebacterium otitidis, bacteria commonly associated with middle ear infections, in the outer ear canals of many healthy individuals. The findings also suggest that microbial populations of the human outer ear, believed to be random in their makeup, may be more consistent than previously thought.

"In any case, the identification of A. otitis and C. otitidis as prevalent commensals of the healthy human outer ear canal indicates a wider niche for these microbes than was previously thought," say the researchers. "Consequently, reevaluation of the roles of these two species in the pathogenesis of the middle ear is warranted."

(D. N. Frank, G. B. Spiegelman, W. Davis, E. Wagner, E. Lyons, N. R. Pace. 2003. Culture-independent molecular analysis of microbial constituents of the healthy human outer ear. Journal of Clinical Microbiology, 41. 1: 295-303.)

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil FibroSleep™ Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid

Natural Remedies

Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
Aching Muscles? Top 10 Nutrients to Take Back Your Life Aching Muscles? Top 10 Nutrients to Take Back Your Life
Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial Mitochondria-Booster NIAGEN® Shows Promise in First Human Clinical Trial
How to Jump-start and Sustain Energy Production in CFS How to Jump-start and Sustain Energy Production in CFS

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map